Navigation Links
SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
Date:5/4/2009

luding, but not limited to, changing market conditions and market size, the acceptance of an IND by the FDA in respect of clinical studies, the submission of a CTA to the appropriate European authorities, the successful initiation and timely and successful completion of clinical studies, the fact that Apo AIMilano is currently a development stage drug, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time-to-time in the Company's ongoing filings with the Canadian securities regulatory authorities which filings can be found at www.sedar.com. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable Canadian securities laws.


'/>"/>
SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys provides update on insulin program
2. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
3. SemBioSys announces senior management changes
4. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
5. SemBioSys begins phase I/II trial of insulin produced in plant seeds
6. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
7. SemBioSys announces second quarter 2008 financial and operational results
8. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
9. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
10. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
11. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
(Date:12/15/2009)... Dec. 15 Aethlon Medical, Inc. (OTC ... Jeff Schorey and Dr. Wayne Comper ... Sciences, Inc. (ESI). Both Dr. Schorey and Dr. ... ESI, a wholly owned subsidiary of Aethlon Medical, ... the Hemopurifier®, a medical device being advanced as ...
(Date:12/15/2009)... The Center for Business Intelligence ... pleased to announce the full agenda for ... Reporting Congress . The forum will take ... 16-17, 2010. ,, Over 1,500 senior-level Finance, ... this premier event since its inception, and ...
(Date:12/14/2009)... Dec. 14 Array BioPharma Inc. (Nasdaq: ... ) today announced that they entered into an ... small-molecule glucokinase activator program, including ARRY-403, currently being ... patients with Type 2 diabetes. ,, ... receive an upfront payment of $60 million and ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Oct. 31 Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ... has granted the Company,s request for an,extension until ... Capital Market,minimum market capitalization requirement of $35 million ... equity in order to remain,listed. There can be ...
... ROCKVILLE, Md., Oct. 31 OriGene Technologies, Inc.,announces ... now in,a GFP (green fluorescence protein) vector, enabling ... over 25,000 human ORF,(open reading frame) clones and ... vector., In early October, the 2008 Nobel ...
... 31 SleepQuest has always,followed the essence of its ... and unexplained health problems related to lack of sleep., ... of identifying and treating sleep disorders. Sleep is a,cornerstone ... wellness factor.,Studies done by the National Commission on Sleep ...
Other Biology Technology:Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 2OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector 2SleepQuest Tireless in Pursuit of Good Sleep 2
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Researchers work on vaccine to improve immune system in newborns 2Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 1Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 2New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 1New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 2European top universities join forces in energy research 8767 1
... Medical Genetics Fellow at The Children,s Hospital in Denver, ... Genzyme/American College of Medical Genetics Foundation (ACMGF) Clinical Genetics ... Clinical Genetics Meeting in Tampa, FL. , The objective ... fellowship program to encourage the recruitment and training of ...
... Montana State University master,s graduate is working with doctors ... handheld laser microscope that could someday reduce the number ... spots on the skin often prompt dermatologists to remove ... best way to diagnose skin cancers, said Chris Arrasmith, ...
... CHAMPAIGN, Ill. Stopping to smell the coffee and ... might do more than just get your juices flowing. It ... , As a former competitive cyclist, University of Illinois kinesiology ... at a coffee shop to fuel up on caffeine prior ...
Other Biology News:Montana State grad's work helps diagnose skin cancer without a biopsy 2Montana State grad's work helps diagnose skin cancer without a biopsy 3A little java makes it easier to jive, researcher says 2A little java makes it easier to jive, researcher says 3A little java makes it easier to jive, researcher says 4
... rapidly and reliably amplify unknown genomic DNA ... provides hassle-free, ready-to use components, at an ... provided in each kit. The Genome Walking ... localized cloning of genomic DNA, isolating promoter ...
... one of the several main MAP kinase ... a sensitive reporter for studying gene regulation ... in sensitivity in comparison to the standard ... the oxidative carboxylation of luciferin, a reaction ...
... Linkage: This CLS number ... created to easily match Cornings ... availability yet, please order under ... or contact customer service for ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
Biology Products: